ストックスクリーナーアプリを入手
0.7218
0.92%
0.0066
アフターアワーズ：
.72
-0.0018
-0.25%
前日終値:
$0.7152
開ける：
$0.73
24時間の取引高:
132.75K
Relative Volume:
0.44
時価総額：
$91.17M
収益：
-
当期純損益:
$-70.78M
株価収益率:
-1.2889
EPS:
-0.56
ネットキャッシュフロー:
$-61.27M
1週間 パフォーマンス:
-3.09%
1か月 パフォーマンス:
-8.37%
6か月 パフォーマンス:
-57.79%
1年 パフォーマンス:
-67.78%
1日の値動き範囲:
$0.7141
$0.75
1週間の範囲:
$0.71
$0.7628
52週間の値動き範囲:
$0.66
$3.09
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
名前
Nautilus Biotechnology Inc
セクター
電話
206-333-2001
住所
2701 EASTLAKE AVE EAST, SEATTLE
NAUT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
0.7218 | 90.33M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-05 | ダウングレード | Goldman | Neutral → Sell |
| 2024-06-27 | 開始されました | Guggenheim | Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2022-01-06 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-11-02 | 開始されました | Cowen | Outperform |
| 2021-08-04 | 開始されました | Goldman | Neutral |
| 2021-07-13 | 開始されました | Jefferies | Buy |
すべてを表示
Nautilus Biotechnology Inc (NAUT) 最新ニュース
Quantitative breakdown of Nautilus Biotechnology Inc. recent moveEntry Point & Stepwise Trade Signal Implementation - Newser
Tools to monitor Nautilus Biotechnology Inc. recovery probabilityAnalyst Upgrade & Low Drawdown Investment Strategies - Newser
Can swing trading help recover from Nautilus Biotechnology Inc. losses2025 Biggest Moves & Real-Time Volume Triggers - Newser
Why Nautilus Biotechnology Inc. stock attracts strong analyst attention2025 Top Decliners & Risk Controlled Daily Plans - Newser
What Fibonacci levels say about Nautilus Biotechnology Inc. reboundWeekly Investment Recap & Advanced Technical Signal Analysis - Newser
Heatmap analysis for Nautilus Biotechnology Inc. and competitorsTrade Volume Report & Fast Momentum Stock Entry Tips - Newser
Is Nautilus Biotechnology Inc. stock poised for growth2025 Top Gainers & Community Verified Trade Signals - Newser
Visual trend scoring systems applied to Nautilus Biotechnology Inc.Market Risk Analysis & Consistent Profit Trading Strategies - Newser
How to integrate Nautilus Biotechnology Inc. into portfolio analysis toolsAI Entry Timing Prediction for Swing Traders - Newser
Can trapped investors hope for a rebound in Nautilus Biotechnology Inc.Breakout Watcher with Entry and Exit Alerts - Newser
Will Nautilus Biotechnology Inc. stock go up soonFree AI Screening for Swing Trade Picks - Newser
Using R and stats models for Nautilus Biotechnology Inc. forecastingStrategy Playbook for Risk Controlled Trades - Newser
Using data filters to optimize entry into Nautilus Biotechnology Inc.Portfolio Allocation Strategy for Stability - Newser
Using Python tools to backtest Nautilus Biotechnology Inc. strategiesFree Confirmed Setup With Expert Accuracy - Newser
Momentum divergence signals in Nautilus Biotechnology Inc. chartReal Market Tracker with Price Action Tools - Newser
Combining price and volume data for Nautilus Biotechnology Inc.Free Entry Zone Strategy for Consistent Profit - Newser
Pattern recognition hints at Nautilus Biotechnology Inc. upsideSwing Trade Watchlist with Entry Zones - Newser
What earnings revisions data tells us about Nautilus Biotechnology Inc.Retirement Investment Outlook and Return Summary - Newser
How Nautilus Biotechnology Inc. stock performs during market volatilityLong-Term Growth Trend Summary With Confidence - Newser
What makes Nautilus Biotechnology Inc. stock price move sharplyFree High Conviction Intraday Stock Signals - Newser
Nautilus Biotechnology Shares Rise 18% After Amazon Discloses Stake - AInvest
Signal strength of Nautilus Biotechnology Inc. stock in tech scannersLong-Term Growth Trend Summary With Confidence - Newser
Nautilus Biotechnology’s Q2 2025 Financial Highlights - TipRanks
Nautilus Biotechnology Inc (NAUT) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
1.56%
大文字化:
|
ボリューム (24 時間):